Abstract: The present invention relates to a bioprocess for recycling waste paper originated from high quality paper comprising the following steps: a) preparation of pulp; b) dilution with water of the pulped material obtained in a) c) enzymatic treatment of pulp; d) addition of inorganic salts and glues; e) dilution with water of the material obtained in d) f) filtration by vacuum; optional press; and g) drying In particular, said high quality paper is printed paper. The present invention also relates to the obtainable product by the above mentioned process. The present invention further relates to the different uses of the product such as building and construction material, eco-packaging material and eco-decorative material.
Abstract: The invention relates to a method of authentication and session key agreement for secure data transmission between a first and second data communication entity in an electronic data transmission system. Furthermore, the invention relates to an electronic transmission system to perform a method of authentication and session key agreement.
Type:
Grant
Filed:
October 4, 2011
Date of Patent:
May 14, 2013
Assignee:
Brandenburgische Technische Universität Cottbus
Abstract: The invention relates to a gas sensor for detecting gas in the air, especially formaldehyde. The sensor comprises at least one gas-sensitive zone which is preferably a layer on a substrate and which contains the ternary compound In4Sn3O12 as the gas-sensitive material. In order to produce the gas-sensitive zone, a flame spray pyrolysis (FSP) is carried out, organometallic compounds of indium and tin being used as the reactants. The gas sensor is especially suitable for online gas detection.
Type:
Application
Filed:
July 7, 2011
Publication date:
May 9, 2013
Applicants:
UNIVERSITÄT BREMEN, EBERHARD KARLS UNIVERSITÄT TÜBINGEN
Abstract: The present invention concerns an (adjuvant) treatment or prevention option for the treatment and prevention of prostate cancer. In particular, it pertains to the provision of recombinant, optimized PAP genes which are useful as DNA vaccines for the above treatment or prevention.
Abstract: The present invention relates to antagonists of the expression and/or the function of the micro RNA miRNA-29 for use in the prevention and/or treatment of aortic aneurysms. Further disclosed is a method for the identification of miRNA-29 antagonists, a pharmaceutical composition comprising said miRNA-29 antagonists and a method for preventing and treating age-related aortic aneurysm formation in a subject in need of such a treatment.
Type:
Application
Filed:
April 1, 2011
Publication date:
May 9, 2013
Applicant:
Johann Wolfgang Goethe-Universitat Frankfurt am Main
Inventors:
Andreas Zeiher, Stefanie Dimmeler, Reinier Boon
Abstract: Method for compensating illumination deficiencies in microscopic “shape from focus (SFF)”, wherein firstly the reflectance of the scene is estimated by way of a projector-camera system and then microscopic “shape from focus (SFF)” is applied to a stack of reflectance maps rather than to the original image data.
Abstract: The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence. This invention provides methods and kits for screening for HNA-3a and HNA-3b specific antibodies, HNA-3a and HNA-3b polypeptides and HNA-3a and HNA-3b nucleic acids in a sample of a biological tissue intended for transplantation.
Type:
Grant
Filed:
November 29, 2011
Date of Patent:
May 7, 2013
Assignees:
Ernst-Moritz-Arndt-Universität Greifswald, DRK Blutspendedienst West GmbH
Inventors:
Andreas Greinacher, Jan Wesche, Juergen Bux, Angelika Reil
Abstract: A method, particularly an enzyme-linked immunosorbent assay (ELISA), for the in-vitro detection of A? autoantibodies in human serum and/or plasma contains the following steps: preparing an antigen-coated solid phase; incubating the solid phase with a blocking solution; incubating the solid phase with a sample to be examined; immunological detection of the A? autoantibodies on the solid phase; and reading the detected results of the solid phase using a reading tool. According to the invention, the preparation of the antigen-coated solid phase advantageously includes incubating the solid phase with a coating solution in which the antigen is dissolved, said antigen having a peptide sequence selected from the group SEQ ID No. 1, SEQ ID No. 2 or SEQ ID No. 3.
Type:
Application
Filed:
July 14, 2010
Publication date:
May 2, 2013
Applicant:
Philipps-Universitat Marvurg
Inventors:
Michael Bacher, Richard Dodel, Karthikeyan Balakrishnan
Abstract: Disclosed herein is a bioreactor (12) for creating and/or conditioning biological tissues and in particular artificial heart valves, vascular grafts and/or cardiovascular patches. The bioreactor (12) comprises a bioreactor housing (30, 32) having a first section (42) and a second section (54), said first section (42) being adapted to receive a nutrition solution, and said second section (54) being adapted to receive said biological tissue, and means (38; 56, 58, 66, 76, 84) for generating and directing a flow of said nutrition solution from said first section (42) to said second section (54) along a first flow path such as to flow along or through at least a portion of said biological tissue, and for directing a back flow of said nutrition solution from said second section (54) to said first section (42) along a second flow path. The flow directing means (56, 58, 66, 76, 84) and said second flow path are contained in said bioreactor housing (30, 32).
Abstract: Compositions of an inhibitor of a polynucleotide for use in treating or preventing bone disorders such as osteoporosis, osteopenia, bone fracture, bone cancer, as well as impaired bone homeostasis. Preferred compounds to be used in these medical interventions are antagonistic compounds, like nucleic acid molecules, directed against miR-31 and derivatives thereof. Also, methods for diagnosing and compositions for use in diagnosing bone disorders. Compounds to be employed in these diagnostic methods and uses include compounds such as miR-31.
Type:
Application
Filed:
May 23, 2011
Publication date:
May 2, 2013
Applicant:
UNIVERSITAT FUR BODENKULTUR WIEN
Inventors:
Johannes Grillari, Elisabeth Schraml, Klaus Fortschegger, Regina Grillari
Abstract: The invention relates to supports consisting of nanoscalar polymer fibers, polymer tubes or hollow fibers for the application and targeted and/or delayed release of ingredients, in particular, agricultural active ingredients. The invention also relates to a method and a device for the production of supports of this type in a charged or empty state. The method and device use electrospinning technology.
Abstract: The present invention relates to a method for purifying analyte molecules and in particular to a component of this type in which a separation section is used for separating analyte molecules and other constituents of a sample, and in which provision is made of at least one sample chamber for receiving a sample containing the analyte molecules and at least one collecting chamber for receiving the purified analyte molecules. According to the invention, the microfluidic component has at least one integrated receptor device for detecting the presence and/or the concentration of the purified analyte molecules. In accordance with one advantageous development of the present invention, the separation section is formed by an electrophoretic gel filtration section.
Abstract: The present invention relates to a method and an apparatus for a fast thermo-optical characterization of particles. In particular, the present invention relates to a method and a device to measure the stability of (bio)molecules, the interaction of molecules, in particular biomolecules, with, e.g. further (bio)molecules, particularly modified (bio)molecules, particles, beads, and/or the determination of the length/size (e.g. hydrodynamic radius) of individual (bio)molecules, particles, beads and/or the determination of length/size (e.g. hydrodynamic radius).
Abstract: Specific alterations in BChE gene have been found which allow determining whether a patient suffers from dementia with Lewy bodies (DLB), and allow distinguishing it from Alzheimer's disease. The invention provides an in vitro method for the diagnosis of DLB comprising determining in a biological sample from a subject, the genotype of the following alterations in butyrylcholinesterase (BChE) gene: the polymorphic sites at position 68974 in NCBI Accession Number NG_009031 (i.e. position 934 in SEQ ID NO: 28), and the polymorphic sites 3687, 4206, 4443, and the poly-thymine region at positions 4780 to 4786, said positions with reference to NCBI Accession Number NG_009031 (i.e. positions 3687, 4206 and 4443 respectively in SEQ ID NO: 1), which corresponds to the nucleotide sequence of human BChE gene.
Type:
Application
Filed:
February 24, 2011
Publication date:
April 25, 2013
Applicants:
FUNDACIÓ INSTITUT D'INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL, UNIVERSITAT AUTÒNOMA DE BARCELONA
Inventors:
Katrin Beyer, Montserrat Domingo Sabat, Aurelio Ariza Fernandez
Abstract: The invention relates to the use of a granulin or a granulin-like compound for producing a pharmaceutical composition for the therapy or prophylaxis of chronic pain, in particular for neuropathic pain.
Type:
Application
Filed:
December 28, 2012
Publication date:
April 25, 2013
Applicant:
JOHANN WOLFGANG GOETHE-UNIVERSITAT FRANKFURT AM MAIN
Inventor:
JOHANN WOLFGANG GOETHE-UNIVERSITAT FRANKFURT AM MAIN
Abstract: A device including a locally modified buried first layer. A second layer is arranged on top of the first layer. The first layer includes at least one modified section and at least one unmodified section. The modified material of the locally modified buried first layer changes or induces mechanical strain in a portion of the second layer which is arranged above the at least one modified section. At least one nanostructure is placed on top of the second layer in an area, which is located above the at least one unmodified section of the first layer or adjacent thereto, said at least one nanostructure being formed by a strain-sensitive third material deposited on the locally strained second layer.
Abstract: The invention pertains to a method for producing molded articles based on aluminum alloys by metal injection molding, comprising the following steps: a) producing a feed-stock by mixing the metals contained in the desired alloy in the form of metal powders and/or one or more metal alloy powders with a binder; b) producing a green body by injection molding said feedstock; c) producing a brown body by at least partially removing the binder from the green body by catalytic and/or solvent and/or thermal debinding; d) sintering the at least partially debound brown body to obtain the desired molded article; characterized in that, in step c), the binder is completely removed, wherein thermal debinding is carried out to remove the (residual) binder, optionally after having carried out one or more previous debinding steps, said thermal debinding being carried out in an atmosphere containing at least 0.5% by volume of oxygen, whereafter the thus obtained, completely debound brown body is sintered.
Type:
Application
Filed:
March 31, 2011
Publication date:
April 25, 2013
Applicants:
Technische Universitat Wien, Rubert Fertinger GMBH, BASF SE
Inventors:
Herbert Danninger, Christian Gierl, Branislav Zlatkov, Johan Ter Maat
Abstract: An apparatus and a method for trapping charged particles and performing controlled interactions between them are provided. The apparatus includes a substrate and RF electrodes and dedicated DC electrodes arranged on the substrate and configured to generate a trapping potential for trapping the charged particles above the substrate. The RF and dedicated DC electrodes include at least one RF trapping electrode configured to be driven with an RF voltage for contributing to the trapping potential, an array of two or more trapping site DC electrodes configured to be biased with a DC voltage for contributing to the trapping potential, and a first individually drivable RF control electrode arranged between a first pair out of the two or more trapping site DC electrodes.
Abstract: The invention relates to an organic photoactive device, especially an organic photovoltaic cell, with a contact and a countercontact as well as with an organic region that is electrically connected to the contact and the countercontact, wherein a photoactive region with a photoactive bulk heterojunction or a flat heterojunction between an electron-conducting organic material and a hole-conducting organic material is formed in the organic region and wherein the hole-conducting organic material and/or the electron-conducting organic material is formed from oligomers according to any one of the following types: conjugated acceptor-donor-acceptor oligomer (A-D-A? oligomer) with an acceptor unit (A) and a further acceptor unit (A?) that are each connected to a donor unit (D), and conjugated donor-acceptor-donor oligomer (D-A-D? oligomer) with a donor unit (D) and a further donor unit (D?) that are each connected to an acceptor unit (A).
Type:
Grant
Filed:
March 3, 2006
Date of Patent:
April 23, 2013
Assignees:
Heliatek GmbH, Universitat ULM
Inventors:
Martin Pfeiffer, Christian Uhrich, Annette Petrich, Rico Schüppel, Kerstin Schulze, Karl Leo, Peter Bäuerle, Egon Reinold, Eduard Brier
Abstract: The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLD18, including tumor-related diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, cancer of the gallbladder, and the metastases thereof.
Type:
Grant
Filed:
May 27, 2008
Date of Patent:
April 23, 2013
Assignees:
Ganymed Pharmaceuticals AG, Johannes Gutenberg-Universitat
Inventors:
Ugur Sahin, Ozlem Tureci, Gunda Brandenburg, Dirk Usener